1. CD40L Deficiency Attenuates Diet-Induced Adipose Tissue Inflammation by Impairing Immune Cell Accumulation and Production of Pathogenic IgG- Antibodies
- Author
-
Maedler, K, Wolf, D, Jehle, F, Rodriguez, AO, Dufner, B, Hoppe, N, Colberg, C, Lozhkin, A, Bassler, N, Rupprecht, B, Wiedemann, A, Hilgendorf, I, Stachon, P, Willecke, F, Febbraio, M, Binder, CJ, Bode, C, Zirlik, A, Peter, K, Maedler, K, Wolf, D, Jehle, F, Rodriguez, AO, Dufner, B, Hoppe, N, Colberg, C, Lozhkin, A, Bassler, N, Rupprecht, B, Wiedemann, A, Hilgendorf, I, Stachon, P, Willecke, F, Febbraio, M, Binder, CJ, Bode, C, Zirlik, A, and Peter, K
- Abstract
BACKGROUND: Adipose tissue inflammation fuels the metabolic syndrome. We recently reported that CD40L--an established marker and mediator of cardiovascular disease--induces inflammatory cytokine production in adipose cells in vitro. Here, we tested the hypothesis that CD40L deficiency modulates adipose tissue inflammation in vivo. METHODOLOGY/PRINCIPAL FINDINGS: WT or CD40L(-/-) mice consumed a high fat diet (HFD) for 20 weeks. Inflammatory cell recruitment was impaired in mice lacking CD40L as shown by a decrease of adipose tissue macrophages, B-cells, and an increase in protective T-regulatory cells. Mechanistically, CD40L-deficient mice expressed significantly lower levels of the pro-inflammatory chemokine MCP-1 both, locally in adipose tissue and systemically in plasma. Moreover, levels of pro-inflammatory IgG-antibodies against oxidized lipids were reduced in CD40L(-/-) mice. Also, circulating low-density lipoproteins and insulin levels were lower in CD40L(-/-) mice. However, CD40L(-/-) mice consuming HFD were not protected from the onset of diet-induced obesity (DIO), insulin resistance, and hepatic steatosis, suggesting that CD40L selectively limits the inflammatory features of diet-induced obesity rather than its metabolic phenotype. Interestingly, CD40L(-/-) mice consuming a low fat diet (LFD) showed both, a favorable inflammatory and metabolic phenotype characterized by diminished weight gain, improved insulin tolerance, and attenuated plasma adipokine levels. CONCLUSION: We present the novel finding that CD40L deficiency limits adipose tissue inflammation in vivo. These findings identify CD40L as a potential mediator at the interface of cardiovascular and metabolic disease.
- Published
- 2012